Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E G Saravolac

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Drug Targets|June 4, 2002
Catalytic DNA: a novel tool for gene suppressionM J Cairns, E G Saravolac, L Q Sun
Immunology|February 1, 1994
Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibodyJ P Wong, L L Stadnyk, E G Saravolac
Antiviral Research|March 1, 1996
Effect of liposome-encapsulation on immunomodulating and antiviral activities of interferon-gamma 1E G Saravolac, B Kournikakis, L Gorton, et al.
Journal of Bacteriology|August 1, 1991
Purification of glucose-inducible outer membrane protein OprB of Pseudomonas putida and reconstitution of glucose-specific poresE G Saravolac, N F Taylor, R Benz, et al.
Laboratory Animal Science|April 1, 1997
Development of a murine hypothermia model for study of respiratory tract influenza virus infectionJ P Wong, E G Saravolac, J G Clement, et al.
Biochemical Society Transactions|February 1, 1996
The use of biotinylation in the detection and purification of affinity labelled Glut-1E G Saravolac, G D Holman, G W Gould, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1995
Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in miceJ P Wong, E G Saravolac, D Sabuda, et al.
Pharmacological Reviews|September 8, 2000
Catalytic nucleic acids: from lab to applicationsL Q Sun, M J Cairns, E G Saravolac, et al.
Gene Therapy|August 6, 1999
Cationic lipid-mediated transfection of cells in culture requires mitotic activityI Mortimer, P Tam, I MacLachlan, et al.
Vaccine|March 21, 2001
Immunoprophylactic strategies against respiratory influenza virus infectionE G Saravolac, D Sabuda, C Crist, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Drug Targets|June 4, 2002
Catalytic DNA: a novel tool for gene suppressionM J Cairns, E G Saravolac, L Q Sun
Immunology|February 1, 1994
Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibodyJ P Wong, L L Stadnyk, E G Saravolac
Antiviral Research|March 1, 1996
Effect of liposome-encapsulation on immunomodulating and antiviral activities of interferon-gamma 1E G Saravolac, B Kournikakis, L Gorton, et al.
Journal of Bacteriology|August 1, 1991
Purification of glucose-inducible outer membrane protein OprB of Pseudomonas putida and reconstitution of glucose-specific poresE G Saravolac, N F Taylor, R Benz, et al.
Laboratory Animal Science|April 1, 1997
Development of a murine hypothermia model for study of respiratory tract influenza virus infectionJ P Wong, E G Saravolac, J G Clement, et al.
Biochemical Society Transactions|February 1, 1996
The use of biotinylation in the detection and purification of affinity labelled Glut-1E G Saravolac, G D Holman, G W Gould, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1995
Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in miceJ P Wong, E G Saravolac, D Sabuda, et al.
Pharmacological Reviews|September 8, 2000
Catalytic nucleic acids: from lab to applicationsL Q Sun, M J Cairns, E G Saravolac, et al.
Gene Therapy|August 6, 1999
Cationic lipid-mediated transfection of cells in culture requires mitotic activityI Mortimer, P Tam, I MacLachlan, et al.
Vaccine|March 21, 2001
Immunoprophylactic strategies against respiratory influenza virus infectionE G Saravolac, D Sabuda, C Crist, et al.
Pageof 2